1997
DOI: 10.1016/s0378-5173(96)04862-4
|View full text |Cite
|
Sign up to set email alerts
|

Amorphous spironolactone-hydroxypropylated cyclodextrin complexes with superior dissolution and oral bioavailability

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
18
1
1

Year Published

2000
2000
2015
2015

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 46 publications
(20 citation statements)
references
References 15 publications
0
18
1
1
Order By: Relevance
“…The possible enhancing mechanisms of CyDs on the bioavailability of drugs in various administration routes are summarized as follows: 1) hydrophilic CyDs increase the solubility, dissolution rate, and wettability of poorly watersoluble drugs, [82][83][84][85][86][87][88][89][90][91][92][93][94][95][96][97][98][99][100][101] 2) CyDs prevent the degradation or disposition of chemically unstable drugs in gastrointestinal tracts as well as during storage, [102][103][104][105][106][107][108][109][110][111] 3) CyDs perturb the membrane fluidity to lower the barrier function, which consequently enhances the absorption of drugs including peptide and protein drugs through the nasal and rectal mucosa, [112][113][114][115][116][117][118][119][120][121] 4) competitive inclusion complexation with third components (bile acid, cholesterol, lipids, etc.) to release the included drug, [122][123][124][1...…”
Section: Enhancement Of Drug Absorption By Hydrophilic Cydsmentioning
confidence: 99%
See 1 more Smart Citation
“…The possible enhancing mechanisms of CyDs on the bioavailability of drugs in various administration routes are summarized as follows: 1) hydrophilic CyDs increase the solubility, dissolution rate, and wettability of poorly watersoluble drugs, [82][83][84][85][86][87][88][89][90][91][92][93][94][95][96][97][98][99][100][101] 2) CyDs prevent the degradation or disposition of chemically unstable drugs in gastrointestinal tracts as well as during storage, [102][103][104][105][106][107][108][109][110][111] 3) CyDs perturb the membrane fluidity to lower the barrier function, which consequently enhances the absorption of drugs including peptide and protein drugs through the nasal and rectal mucosa, [112][113][114][115][116][117][118][119][120][121] 4) competitive inclusion complexation with third components (bile acid, cholesterol, lipids, etc.) to release the included drug, [122][123][124][1...…”
Section: Enhancement Of Drug Absorption By Hydrophilic Cydsmentioning
confidence: 99%
“…Combinations of CyDs with pharmaceutical excipients [139][140][141] or with different kind of CyDs 142,143) were successfully applied to obtain a prolonged release of water-soluble drugs. The gel forming property of HP-b-CyD is useful to design the prolonged release of metoprorol.…”
Section: )mentioning
confidence: 99%
“…3,4) In the pharmaceutical field this complexation phenomenon has been extensively applied to enhance the solubility, dissolution rate, and bioavailability of sparingly soluble drugs in gastrointestinal fluids. [5][6][7][8][9][10] Because of the increasing interest in CDs and their inherent usefulness, several studies have been conducted to clarify the mechanism of complexation.…”
mentioning
confidence: 99%
“…However, highest solubility was observed in water because of its salt form physical state. Solubilisation of poorly soluble drugs complexed with cyclodextrin, because of a rise in dissolution kinetics, is often mentioned as the reason for improved drug bioavailability when complexed with cyclodextrins and used for dosing [20]. Because pH varies throughout the gastrointestinal tract, pH-dependent solubility studies would benefit us greatly in assessing the oral bioavailability of NM β-CD complexes.…”
Section: Discussionmentioning
confidence: 99%